Overview

[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

Status:
Completed
Trial end date:
2021-06-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of KSR-001 in patients with Dry Eye Syndrome
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Kukje Pharma
Collaborator:
Samil Pharmaceutical Co., Ltd.